Cancer screening
FDA advisers back a blood test for 50 cancers. What it can and cannot do.
On September 23, an FDA advisory panel voted to support Galleri, GRAIL’s blood test for more than 50 types of cancer. It is a real step toward the first approved test of its kind, and a smaller one than the headlines suggest.
Read the article